GMP-Compliant Pharma Products at Competitive Prices

/ Product Insights / By

DMSCAREPHARMA is a professional pharmaceutical manufacturer and exporter based in China.

We supply a full range of pharmaceutical API, finished medicines, injections, tablets, capsules and health supplements.

Core products cover Paracetamol, Ibuprofen, Amoxicillin, Ceftriaxone, Artesunate, Glutathione and Biotin.

With GMP compliance, strict quality control and stable bulk supply, we serve global pharma clients, hospitals and distributors.

Choose DMSCAREPHARMA for high-quality pharma products, competitive price and one-stop sourcing service.

No products available.

Who we are

Sinophare Bio-technology Co., Ltd. is a Chinese pharmaceutical manufacturer and exporter holding drug manufacturing licences DML Jin20160068 (medicines) and Jin20160069 (paracetamol API). We manufacture and export finished dosage forms and pharmaceutical ingredients, and we supply them against a written specification with the documentation a registration file needs.

What we manufacture

The catalogue runs to 186 finished dosage forms in nine pharmaceutical presentations and fourteen therapeutic areas:

  • Dosage forms — injections and infusions, tablets, capsules, ophthalmic preparations, suppositories, oral suspensions, syrups, granules and medical consumables.
  • Therapeutic coverage — antimalarials and ACTs, antibacterials, analgesics and NSAIDs, ophthalmology, diabetes and insulin, maternal and newborn care, emergency and critical care, gastrointestinal and antiemetics, IV fluids and parenteral nutrition, oncology, antifungals and antivirals, vitamins and clinical nutrition, medical consumables, and sexual and reproductive health.

Browse the full catalogue · Therapeutic ranges

Manufacturing and quality system

Production runs in standardised GMP workshops with an independent R&D laboratory and a complete quality-inspection centre. Materials are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and finished-product testing. Every batch is released on a certificate of analysis covering identification, assay, related substances and, for parenterals, sterility and bacterial endotoxins.

Testing capability covers HPLC and GC assay and impurity methods, dissolution, uniformity of dosage units, water content, pH, microbiological limits and, for sterile products, sterility and endotoxin testing.

Why our portfolio is anchored in the WHO Model List

The range is deliberately built around medicines that national programmes are obliged to procure. The WHO Model List of Essential Medicines specifies not only the molecule but the presentation — strength, dosage form and, in many cases, the number of units — so an essential-medicines tender is a specification exercise before it is a price exercise. WHO Model List (24th list)

  • Antibacterials are classified for stewardship. The WHO AWaRe framework groups antibiotics into Access, Watch and Reserve, and national programmes increasingly write the AWaRe group into the specification. Knowing which group a product belongs to changes who may buy it and how it may be promoted. WHO AWaRe classification
  • Malaria treatment is a combination protocol. Published malaria guidance treats uncomplicated falciparum malaria with a three-day artemisinin-based combination therapy, and severe malaria with a parenteral followed by a full oral course. We supply both halves of that protocol. MSF medical guidelines — malaria
  • Strength discipline is a safety issue, not a marketing one. The Model List warns, for example, that offering two near-identical paracetamol oral liquid strengths on one market causes prescribing and dispensing errors. We will supply a single strength per market on request.

Documentation and registration support

  • Certificate of analysis with assay, related substances, dissolution and impurity data per batch.
  • Stability data and the shelf-life justification for the marketed pack.
  • CTD dossier modules 1–5 in editable and PDF form.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation reports and the specification agreed with your quality team.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.

Export and logistics

We export to buyers in the Middle East, Africa, Southeast Asia, Latin America and the CIS. Consignments ship with commercial invoice, packing list, certificate of origin, GMP certificate, certificate of analysis and, where required, the free-sale certificate from the country of manufacture. Artwork can be produced in English, Arabic, French, Russian and Spanish, and in your own brand where the destination labelling rules allow it.

Questions buyers ask

What makes a supplier usable for an essential-medicines tender?

The specification, the dossier and the documentation that ships with the batch. A tender that names the molecule but not the presentation, the monograph and the release tests is not yet a specification, and a supplier who cannot produce the registration file cannot be awarded.

Do you supply pharmaceutical ingredients as well as finished forms?

Yes. Paracetamol API is covered by DML Jin20160069, and other ingredients are supplied against a written specification with the same release testing and documentation discipline.

Which markets do you already support with dossiers?

Buyers in the Middle East, Africa and Southeast Asia are the largest group, with additional programmes in Latin America and the CIS. Tell us the destination and we confirm what the authority there expects.

Company profile · Request a quotation

Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.